PDF(922 KB)
PDF(922 KB)
PDF(922 KB)
布拉氏酵母菌散剂联合阿奇霉素序贯治疗肺炎支原体肺炎继发腹泻患儿的临床研究
Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia
目的 探讨布拉氏酵母菌散剂联合阿奇霉素序贯治疗肺炎支原体肺炎继发腹泻患儿的效果。方法 选取2015年6月至2017年3月肺炎支原体肺炎继发腹泻患儿88例为研究对象，随机数字表法分为对照组（n=44）和研究组（n=44）。对照组采取常规治疗+阿奇霉素序贯治疗，研究组在对照组基础上口服布拉氏酵母菌散剂，用药至阿奇霉素序贯治疗结束。疗程结束后统计比较两组临床症状改善时间、住院时间，以及临床疗效、治疗前后大便次数、肠道菌群失调情况、不良反应发生率。结果 研究组临床症状改善时间及住院时间较对照组缩短（P < 0.05）；研究组治疗有效率高于对照组（P < 0.05）；治疗第3天及第5天研究组患儿大便次数较对照组明显减少（P < 0.05）；两组肠道菌群失调率比较，研究组较对照组低（P < 0.05）；两组不良反应发生率比较差异无统计学意义（P > 0.05）。结论 采用布拉氏酵母菌散剂联合阿奇霉素序贯治疗肺炎支原体肺炎继发腹泻，可有效改善患儿临床症状，缩短住院时间，减少大便次数，改善肠道菌群失调情况，提高治疗效果，且不会增加不良反应发生风险。
Objective To investigate the clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in the treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia.Methods A total of 88 children with diarrhea secondary to Mycoplasma pneumoniae pneumonia between June 2015 and March 2017 were divided into control group and study group using a random number table, with 44 children in each group. The children in the control group were given routine treatment combined with azithromycin sequential therapy, and those in the study group were given oral Saccharomyces boulardii powder in addition to the treatment in the control group until the end of azithromycin sequential therapy. After the treatment ended, the two groups were compared in terms of time to improvement of clinical symptoms, length of hospital stay, clinical outcome, defecation frequency before and after treatment, condition of intestinal dysbacteriosis, and incidence of adverse events.Results Compared with the control group, the study group had significantly shorter time to improvement of clinical symptoms and length of hospital stay (P < 0.05). The study group had a significantly higher response rate than the control group (P < 0.05). On days 3 and 5 of treatment, the study group had a significant reduction in defecation frequency compared with the control group (P < 0.05). The study group had a significantly lower rate of intestinal dysbacteriosis than the control group (P < 0.05). There was no significant difference in the incidence of adverse events between the two groups (P > 0.05).Conclusions In the treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia, Saccharomyces boulardii powder combined with azithromycin sequential therapy can improve clinical symptoms, shorten the length of hospital stay, reduce defecation frequency and the incidence of intestinal dysbacteriosis, and improve clinical outcomes, and does not increase the risk of adverse events.
肺炎支原体肺炎 / 腹泻 / 布拉氏酵母菌散剂 / 阿奇霉素 / 儿童
Mycoplasma pneumoniae pneumonia / Diarrhea / Saccharomyces boulardii powder / Azithromycin / Child
[1] 柯莉芹, 王凤美, 李银洁, 等. 儿童肺炎支原体肺炎流行病学特征[J]. 中国当代儿科杂志, 2013, 15(1):33-36.
[2] Sharma L, Losier A, Tolbert T, et al. Atypical pneumonia:updates on legionella, chlamydophila, and Mycoplasma pneumonia[J]. Clin Chest Med, 2017, 38(1):45-58.
[3] 王菲, 尚云晓. 肺炎支原体肺炎发病机制及相关临床问题[J]. 中国实用儿科杂志, 2015, 30(3):184-189.
[4] 徐艳丽. 儿童肺炎支原体感染应用阿奇霉素联合头孢类抗生素及布地奈德雾化吸入治疗的效果研究[J]. 国际儿科学杂志, 2016, 43(5):417-419.
[5] Burr SE, Milne S, Jafali J, et al. Mass administration of azithromycin and Streptococcus pneumoniae carriage:cross-sectional surveys in the Gambia[J]. Bull World Health Organ, 2014, 92(7):490-498.
[6] 焦素敏, 沙玉英, 冯雪莉. 支原体肺炎患儿阿奇霉素治疗前后C-反应蛋白及心肌酶变化的临床研究[J]. 中华医院感染学杂志, 2015, 25(21):4888-4890.
[7] 苏青, 钟永兴. 双歧杆菌三联活菌散治疗小儿肺炎继发腹泻的临床疗效及其影响因素分析[J]. 中国医师进修杂志, 2013, 36(12):33-35.
[8] Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries:impact on mortality and morbidity due to diarrhea, pneumonia and malaria[J]. BMC Public Health, 2011, 11 Suppl 3:S23.
[9] 李自华. 小儿肺炎继发腹泻的相关危险因素及培菲康的预防作用[J]. 实用临床医药杂志, 2013, 17(11):155-156.
[10] 张颖. 小儿肺炎继发腹泻相关因素分析及微生态制剂的预防作用分析[J]. 中国妇幼保健, 2015, 30(33):5790-5791.
[11] Schlaudecker EP, Steinhoff MC, Moore SR. Interactions of diarrhea, pneumonia, and malnutrition in childhood:recent evidence from developing countries[J]. Curr Opin Infect Dis, 2011, 24(5):496-502.
[12] 何耀众. 双歧三联活菌治疗小儿肺炎继发腹泻的疗效及影响因素分析[J]. 临床肺科杂志, 2015, 20(9):1712-1714.
[13] 孙佃军. 布拉酵母菌预防小儿肺炎继发腹泻的临床研究[J]. 山西医药杂志, 2013, 42(5):319-320.
[14] Abbas Z, Yakoob J, Jafri W, et al. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome:a randomized trial[J]. Eur J Gastroenterol Hepatol, 2014, 26(6):630-639.
[15] 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013修订)(下)[J]. 中华儿科杂志, 2013, 51(11):856-862.
[16] 中华人民共和国卫生部.医院感染诊断标准(试行)[J]. 现代实用医学, 2003, 15(7):460-465.
[17] 任宏伟, 行敏, 苏艳琦, 等. 布拉氏酵母菌治疗小儿肺炎继发腹泻的临床疗效观察[J].中国疗养医学, 2017, 26(5):533-535.
[18] 张秀荣. 肠道菌群粪便涂片检查图谱[M]. 人民军医出版社, 2000:4-18.
[19] Dumke R, Schnee C, Pletz M W, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012[J]. Emerg Infect Dis, 2015, 21(3):426-434.
[20] 刘金荣, 赵顺英. 难治性肺炎支原体肺炎的发病机制[J]. 临床儿科杂志, 2013, 31(12):1186-1188.
[21] 许全珍. 阿奇霉素序贯疗法治疗小儿支原体肺炎临床疗效及安全性研究[J]. 河北医学, 2013, 19(1):120-122.
[22] Venner M, Credner N, Lämmer M, et al. Comparison of tulathromycin, azithromycin and azithromycin-rifampin for the treatment of mild pneumonia associated with Rhodococcus equi[J]. Vet Rec, 2013, 173(16):397.
[23] 朱庆龄, 杨声坪, 叶新华, 等. 阿奇霉素与红霉素治疗小儿支原体肺炎的系统评价[J].儿科药学杂志, 2013, 19(11):10-15.
[24] 邵新环, 李倩倩, 向治纬, 等. 儿童难治性肺炎支原体肺炎临床特征及治疗[J]. 临床儿科杂志, 2015, 33(11):958-961.
[25] Chisti MJ, Ahmed T, Faruque AS, et al. Clinical and laboratory features of radiologic pneumonia in severely malnourished infants attending an urban diarrhea treatment center in Bangladesh[J]. Pediatr Infect Dis J, 2010, 29(2):174-177.
[26] 钱月梅. 儿童肺炎继发性腹泻的危险因素及布拉酵母菌散的疗效分析[J]. 儿科药学杂志, 2015, 21(10):26-29.
[27] 盛晓翠, 张莹. 布拉氏酵母菌散剂在婴儿肺炎继发性腹泻中的疗效分析[J]. 昆明医学院学报, 2011, 32(5):148-149.
[28] 李鉴州. 布拉氏酵母菌散治疗小儿肺炎继发腹泻的效果评价[J]. 中国药物经济学, 2016, 11(12):84-86.
[29] Feizizadeh S, Salehi-Abargouei A, Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea[J]. Pediatrics, 2014, 134(1):e176-e191.
[30] 宣奇志. 布拉氏酵母菌联合阿奇霉素序贯疗法对小儿肺炎支原体肺炎继发腹泻的预防效果[J]. 中国药物经济学, 2017, 12(3):22-25.
[31] 郑申健, 舒琼璋, 刘贺临. 布拉氏酵母菌散剂预防支原体肺炎继发腹泻的临床研究[J].临床肺科杂志, 2014, 19(4):653-655.
[32] 佘萍莉, 樊启红, 吴婷婷, 等. 布拉氏酵母菌治疗新生儿肺炎继发腹泻的疗效观察[J].长江大学学报(自科版)医学下旬刊, 2013, 10(11):31-32.
